iShares US Pharmaceuticals ETF
IHE
IHE
91 hedge funds and large institutions have $205M invested in iShares US Pharmaceuticals ETF in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 47 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
52% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 23
72% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 47
Holders
91
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$7.43M | |
| 2 | +$5.01M | |
| 3 | +$3.64M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$3.09M |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$2.25M |
Top Sellers
| 1 | -$21.6M | |
| 2 | -$20.5M | |
| 3 | -$11M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$10.1M |
| 5 |
LPL Financial
San Diego,
California
|
-$7.53M |